Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Journal of Clinical Medicine
|
April 30, 2021
Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them
Angelica Petrillo, Emilio Francesco Giunta, Annalisa Pappalardo, et al.
European Urology Oncology
|
August 13, 2023
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis
Carlo Messina, Emilio Francesco Giunta, Alessio Signori, et al.
Scientific Reports
|
October 20, 2020
Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients
Emilio Francesco Giunta, Giusi Barra, Vincenzo De Falco, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 6, 2019
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models
Valentina Belli, Nunzia Matrone, Stefania Napolitano, et al.
Journal of Personalized Medicine
|
April 3, 2021
Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New Results
Teresa Troiani, Stefania Napolitano, Gabriella Brancaccio, et al.
Cancers
|
July 9, 2022
Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR
Emilio Francesco Giunta, Vincenzo De Falco, Pietro Paolo Vitiello, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 29, 2024
Correlation of [<sup>68</sup>Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients
Emilio Francesco Giunta, Paola Caroli, Emanuela Scarpi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 27, 2025
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study
Irene Marini, Emilio Francesco Giunta, Silvia Nicolini, et al.
ESMO Open
|
November 2, 2019
Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: a case report and a review of literature
Giuseppe Viscardi, Nicoletta Zanaletti, Maria Giovanna Ferrara, et al.
Medicine
|
May 25, 2019
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant
Vincenzo De Falco, Maria Iole Natalicchio, Stefania Napolitano, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Journal of Clinical Medicine
|
April 30, 2021
Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them
Angelica Petrillo, Emilio Francesco Giunta, Annalisa Pappalardo, et al.
European Urology Oncology
|
August 13, 2023
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis
Carlo Messina, Emilio Francesco Giunta, Alessio Signori, et al.
Scientific Reports
|
October 20, 2020
Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients
Emilio Francesco Giunta, Giusi Barra, Vincenzo De Falco, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 6, 2019
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models
Valentina Belli, Nunzia Matrone, Stefania Napolitano, et al.
Journal of Personalized Medicine
|
April 3, 2021
Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New Results
Teresa Troiani, Stefania Napolitano, Gabriella Brancaccio, et al.
Cancers
|
July 9, 2022
Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR
Emilio Francesco Giunta, Vincenzo De Falco, Pietro Paolo Vitiello, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 29, 2024
Correlation of [<sup>68</sup>Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients
Emilio Francesco Giunta, Paola Caroli, Emanuela Scarpi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 27, 2025
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study
Irene Marini, Emilio Francesco Giunta, Silvia Nicolini, et al.
ESMO Open
|
November 2, 2019
Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: a case report and a review of literature
Giuseppe Viscardi, Nicoletta Zanaletti, Maria Giovanna Ferrara, et al.
Medicine
|
May 25, 2019
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant
Vincenzo De Falco, Maria Iole Natalicchio, Stefania Napolitano, et al.
Page
of 6